MELBOURNE, AUSTRALIA and AUCKLAND, NEW ZEALAND--(Marketwire - April 01, 2008) - Living Cell Technologies Limited (ASX: LCT) (PINKSHEETS: LVCLY) today announced that Dr. Paul Tan, LCT CEO and Dr. Anil K. Anal, LCT Material Scientist, presented some data at a session on nanotechnology at the NZBio 2008 Conference in Auckland, New Zealand. Their presentation showcased the company’s proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell®, to be implanted without the use of toxic immune suppressive drugs.
